Alternative splicing in prostate cancer progression and therapeutic resistance

C Rawat, HV Heemers - Oncogene, 2024 - nature.com
Prostate cancer (CaP) remains the second leading cause of cancer deaths in western men.
CaP mortality results from diverse molecular mechanisms that mediate resistance to the …

Non-canonical functions of spliceosome components in cancer progression

OM Ivanova, KS Anufrieva, AN Kazakova… - Cell Death & …, 2023 - nature.com
Dysregulation of pre-mRNA splicing is a common hallmark of cancer cells and it is
associated with altered expression, localization, and mutations of the components of the …

Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence

AC Fuentes-Fayos, ME G-García, JM Pérez-Gómez… - …, 2023 - thelancet.com
Background Glioblastoma is one of the most devastating and incurable cancers due to its
aggressive behaviour and lack of available therapies, being its overall-survival from …

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3

AC Fuentes-Fayos, MC Vázquez-Borrego… - Brain, 2020 - academic.oup.com
Glioblastomas remain the deadliest brain tumour, with a dismal∼ 12–16-month survival
from diagnosis. Therefore, identification of new diagnostic, prognostic and therapeutic tools …

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing

JL López-Cánovas, N Hermán-Sánchez… - … & Molecular Medicine, 2023 - nature.com
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing
machinery components (spliceosome and splicing factors) and aberrant expression of …

[HTML][HTML] The extracellular matrix stiffening: a trigger of prostate cancer progression and castration resistance?

C Luthold, T Hallal, DP Labbé, F Bordeleau - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer is a malignancy that affects a high number of men all over
the world. When indolent, prostate cancer can remain silent for years without needing …

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer

AJ Montero-Hidalgo, JM Jiménez-Vacas… - Science …, 2024 - science.org
Despite novel therapeutic strategies, advanced-stage prostate cancer (PCa) remains highly
lethal, pointing out the urgent need for effective therapeutic strategies. While dysregulation …

SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances

AC Fuentes-Fayos, JM Pérez-Gómez… - Journal of Experimental …, 2022 - Springer
Background Glioblastoma is one of the most devastating cancer worldwide based on its
locally aggressive behavior and because it cannot be cured by current therapies. Defects in …

Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer

W Yang, L Hong, L Guo, Y Wang, X Han, B Han, Z **ng… - Cell Discovery, 2024 - nature.com
Metabolic dysregulation is prominent in triple-negative breast cancer (TNBC), yet
therapeutic strategies targeting cancer metabolism are limited. Here, utilizing multiomics …

MARVEL: an integrated alternative splicing analysis platform for single-cell RNA sequencing data

WX Wen, AJ Mead, S Thongjuea - Nucleic Acids Research, 2023 - academic.oup.com
Alternative splicing is an important source of heterogeneity underlying gene expression
between individual cells but remains an understudied area due to the paucity of …